Moderna (NASDAQ: MRNA) Q3 2024 Earnings Call Nov 07, 2024, 8:00 a.m. ET Good day, and thank you for standing by. Welcome to ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

CureVac (CVAC) made meaningful progress in restructuring its operations during the third quarter by implementing significant cost-cutting ...

According to UNICEF's State of the World's Children 2023 report, in Latin America and the Caribbean, 6.8 million children did ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

The latest trading session saw Moderna (MRNA) ending at $53.80 ... while the tech-heavy Nasdaq added 0.27%. Prior to today's trading, shares of the biotechnology company had lost 17.64% over ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on MRNA: Moderna NewsMORE ...

Good morning and thank you all for joining us on today's call. It's an exciting time for Wave ... These targets include ...

Working with mice, hamsters and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 vaccine ... according to a Penn news release about the study.